Business
Oura said the deal could provide new opportunities in payments and data security.
The startup plans to use AI-backed retinal imaging to find early signs of disease based on tech from Australian company Eyetelligence.
In a letter to employees, CEO Ayub Khattak said the diagnostics company's new initiatives are "progressing well but are still early in terms of revenue generation."
Patients in Emory's behavioral health program will utilize NeuroFlow's platform to have access to psychotherapy content between scheduled visits.
This is the second round of layoffs in less than a year.
Also, Startoon has obtained a US FDA clearance for its wearable recovery tracking device.
The company reported a larger net loss in the first quarter that included a $330.3 million noncash goodwill impairment charge.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The company also laid off workers in the U.K. and Israel as it shifts focus to the U.S. market.
The company reported $33.3 million in revenue for Q1 2023 and a net loss of $8.8 million.